Community/Retail

Amid various obstacles, health care providers and pharmacists can initiate measures to enhance compensation for pharmacy services in managed care.

In clinical trials of patients with Crohn disease, upadacitinib demonstrated early and long-term symptom relief, as well a visible reduction of damage to the intestinal lining caused by excess inflammation.

Study finds that a more accurate estimate of the burden of RSV disease will facilitate appropriate decision making regarding the use of preventive interventions, such as vaccination.

As demand increases, pharmacies can diversify by offering brain-function assessments to patients.

Improving awareness and getting involved in local or national initiatives can enable pharmacists to make change.

Christina Madison sat down with Walter Oronsaye, known as the Phit Pharmacist, to discuss over prescribing as well as social media as a tool for pharmacists.

At least 150 minutes per week of moderate intensity aerobic activity, or 75 minutes of vigorous intensity aerobic activity found to improve outcomes in patients with flu or pneumonia.

Federal legislation addresses variety of issues and seeks to build on gains made under the Affordable Care Act.

Experts have seen the value of technology in the clinical trial space because it helps to remove natural bias that can leads to inaccuracies in data collection.

Good practice for older adults is that calories should go down while nutrient intake goes up as they age.

Common chronic pain conditions included in the analysis were fibromyalgia, neuropathic pain, and musculoskeletal pain.

Health care professionals should educate patients that it is possible to effectively manage pain without opioids.

Skinvive by Juvéderm is a first of its kind medication to create skin smoothness that lasts 6 months with optimal treatment.

Teva is unable to meet demand for dextroamphetamine/amphetamine, and other companies struggle to keep up.

Patients who did not have health care coverage were found to have a significantly higher mean HbA1c levels among adults with diabetes.

Study evaluates the effect of long-acting monoclonal antibodies tixagevimab and cilgavimab treating COVID-19 symptoms and viral shedding.

Hospitalization costs from respiratory syncytial virus infection are driven by older age and comorbidities.

Low compensation, stressful environment spark technician exodus; replacing them has been difficult.

Since the 2018 guideline’s publication, additional non-statin therapies such as bempedoic acid, evinacumab, and inclisiran, have been approved by the FDA for the management of hypercholesterolemia.

Approximately 56.6% of young adults with advanced heart disease prefer to be involved in end-of-life decisions if they were very ill, with nearly all patients saying that they would also like their parents to be involved.

The sleep hormone decreased intestinal homeostasis, which may augment inflammation that causes tissue and intestinal damage.

Investigators of the phase 2 study also found a comparable reactogenicity to the individual influenza and COVID-19 vaccines from Novavax or authorized vaccine comparators.

Options abound, but pharmacists should address barriers to prevent inequities for patients when they seek treatment.

Patients with HIV were no less likely to show a worse clinical presentation following tecovirimat treatment.

Brexpiprazole was associated with a statistically and clinically meaningful improvement in agitative behaviors caused by dementia compared to placebo.

Nonprescription products manage mild to moderate symptoms, but more severe cases need further medical evaluation.

Harsha Rajasimha, PhD, discusses current challenges leading to clinical trial delays, such as the “valley of death.”

Although this should be a relatively routine process, the national conversations around abortion and contraception have brought more attention to the decision.

BI 456906 activates the GLP-1 and glucagon receptors that help to control metabolic function, and could potentially offer clinically relevant benefits for those living with obesity or overweight without type 2 diabetes.

Study shows that the nervous system of individuals experiencing post-COVID-19 fatigue is underactive in 3 key areas.